Advertisement
Screener

EMBECTA CORP. (EMBC) Debt / Equity

EMBECTA CORP. (EMBC) Debt / Equity

  • 2026-06-30: Debt/Equity Ratio -2.37.
  • 2026-03-31: Debt/Equity Ratio -2.12.
  • 2025-12-31: Debt/Equity Ratio -2.22.
  • 2025-09-30: Debt/Equity Ratio -2.15.

Complete source-backed debt/equity ratio history.

Available history
2021-09-30 to 2026-06-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-30-2.37
2026-03-31-2.12
2025-12-31-2.22
2025-09-30-2.15
2025-06-30-2.19
2025-03-31-2.06
2024-12-31-2.01
2024-09-30-2.13
2024-06-30-2.1
2024-03-31-2.08
2023-12-31-2.02
2023-09-30-1.95
2023-06-30-1.98
2023-03-31-1.95
2022-12-31-1.92
2022-09-30-1.8
2022-06-30-1.9
2022-03-31-1.46
2021-09-300

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-09-30-2.15
2024-09-30-2.13
2023-09-30-1.95
2022-09-30-1.8
2021-09-300

Similar stocks

Stock NameCountryMarket CapPE Ratio
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
Orthofix Medical Inc. (OFIX)$0.373B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52